398 related articles for article (PubMed ID: 37166619)
1. Androgenetic Alopecia: Therapy Update.
Devjani S; Ezemma O; Kelley KJ; Stratton E; Senna M
Drugs; 2023 Jun; 83(8):701-715. PubMed ID: 37166619
[TBL] [Abstract][Full Text] [Related]
2. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
3. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
4. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Manabe M; Tsuboi R; Itami S; Osada SI; Amoh Y; Ito T; Inui S; Ueki R; Ohyama M; Kurata S; Kono T; Saito N; Sato A; Shimomura Y; Nakamura M; Narusawa H; Yamazaki M;
J Dermatol; 2018 Sep; 45(9):1031-1043. PubMed ID: 29863806
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
Gupta AK; Talukder M; Shemer A
Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Adil A; Godwin M
J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Nestor MS; Ablon G; Gade A; Han H; Fischer DL
J Cosmet Dermatol; 2021 Dec; 20(12):3759-3781. PubMed ID: 34741573
[TBL] [Abstract][Full Text] [Related]
8. What's New in Therapy for Male Androgenetic Alopecia?
Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
[TBL] [Abstract][Full Text] [Related]
9. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
10. Androgenetic Alopecia: An Update of Treatment Options.
Kelly Y; Blanco A; Tosti A
Drugs; 2016 Sep; 76(14):1349-64. PubMed ID: 27554257
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.
Sadeghzadeh Bazargan A; Tavana Z; Dehghani A; Jafarzadeh A; Tabavar A; Alavi Rad E; Goodarzi A
J Cosmet Dermatol; 2024 Feb; 23(2):543-551. PubMed ID: 37650533
[TBL] [Abstract][Full Text] [Related]
12. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
13. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
14. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK; Talukder M; Williams G
J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
Van Neste D
Skin Res Technol; 2020 Jul; 26(4):542-557. PubMed ID: 31957152
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
18. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
19. Pediatric androgenetic alopecia: an updated review.
Gomes TF; Soares RO
J Dtsch Dermatol Ges; 2023 Jan; 21(1):19-25. PubMed ID: 36688435
[TBL] [Abstract][Full Text] [Related]
20. Androgenetic alopecia: an update.
Kaliyadan F; Nambiar A; Vijayaraghavan S
Indian J Dermatol Venereol Leprol; 2013; 79(5):613-25. PubMed ID: 23974579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
